Skip to content

Age-Related Eye Diseases: Bioregenerative Medicine and Stem Cell Therapy

Authors: Prof. Dr. Mike K.S. Chan and Prof. Dr. Yuriy Nalapko
Published by: EUROPEAN WELLNESS ACADEMY
ISBN: 9781662982521 eISBN: 9781662982538
Library of Congress Control Number: 2026955545

Share this post:

Age-Related Eye Diseases: Bioregenerative Medicine and Stem Cell Therapy

Age-Related Eye Diseases: Bioregenerative Medicine and Stem Cell Therapy

Authors: Prof. Dr. Mike K.S. Chan and Prof. Dr. Yuriy Nalapko
Published by: EUROPEAN WELLNESS ACADEMY
ISBN: 9781662982521 eISBN: 9781662982538
Library of Congress Control Number: 2026955545

Select book language to read:

Age-Related Eye Diseases EN

English

Age-Related Eye Diseases CS

Chinese Simplified*

Age-Related Eye Diseases CT

Chinese Traditional*

Age-Related Eye Diseases AR

Arabic*

Age-Related Eye Diseases ES

Spanish*

Age-Related Eye Diseases PT

Portuguese*

Age-Related Eye Diseases JA

Japanese*

Age-Related Eye Diseases KO

Korean*

Age-Related Eye Diseases RU

Russian*

Age-Related Eye Diseases TH

Thai*

Age-Related Eye Diseases VI

Vietnamese*

Age-Related Eye Diseases ID

Indonesian*

* This is an AI machine-translated version; for precise information, please refer to the original published English language.

When vision begins to fail, where does hope come from? Age-related macular degeneration — the leading cause of irreversible blindness in the elderly — is no longer a destiny of irreversible decline. This book assembles the emerging science of ocular repair into a single, forward-looking narrative, one in which age-related diseases are understood not merely as a disease of the eye but as a bioenergetic crisis rooted in the failing mitochondria of the eye cells. When aging, genetics, and environmental stress uncouple metabolic partnership of retina, optic nerve, brain, and other organs and tissues, energy supply falters, reactive oxygen species accumulate, and chronic inflammation flourishes. True healing, the authors argue, begins with restoring this metabolic coupling — and no single agent can accomplish it alone.

The path forward is deliberately multimodal. Lifestyle modification eases the pro-inflammatory burden imposed by oxidative stress and airborne pollutants such as motor vehicle exhaust, which accelerate lipofuscin accumulation and drusen formation. Peptide therapies bolster mitochondrial biogenesis. Stem cell transplantation offers a structural replacement for atrophic tissue. Around these cellular strategies, exosome-secreting cells and mitochondrial replacement therapy are being explored to rejuvenate the host tissue environment. The regenerative medicine field already counts more than two hundred interventional trials in ophthalmology — a measure of how swiftly these ideas are moving toward the clinic.

Written for clinicians moving from palliation to prevention, the book pleads for combination over monotherapy. It walks the reader through the pathways that govern mitochondrial biogenesis and antioxidant defense; the omega-3-rich diets and lipid mediators that reinforce retinal epithelial integrity; and the restoration of autophagic flux. It also confronts the field’s unsettled questions: why transplanted cells and peptides must achieve durable metabolic integration and immune tolerance, why drug responses vary so widely among patients, and why early complement blockade may prevent the cascading degeneration of the choroid.

Beneath every strategy lies a single conviction: the aging eye is not beyond repair. The next era of ophthalmology will be defined not by managing blindness, but by preventing it.

Table of Content

LIST OF ABBREVIATIONS XI
PREFACE XIII
INTRODUCTION 1
PART 1: GENERAL OPHTHALMOLOGY FROM THE PERSPECTIVE OF AGE–RELATED CHANGES
CHAPTER 1: CLINICAL ANATOMY, HISTOLOGY AND PHYSIOLOGY OF OCULAR STRUCTURES 7
1.1. Cornea 8
1.2. Lens 13
1.3. Retina 17
1.4. Ocular muscles 23
1.5. Ophthalmic arteries 25
1.6. Optic nerve 28
1.7. Occipital lobe analyzer 30
CHAPTER 2: EPIDEMIOLOGY OF AGE–RELATED EYE DISEASES 33
2.1. Global prevalence 34
2.2. Demographic influences 36
2.3. Trends in incidence 38
CHAPTER 3: CLASSIFICATION OF AGE–RELATED EYE DISEASES 39
3.1. Degenerative diseases 40
3.2. Vascular diseases 43
3.3. Metabolism-related diseases 44
3.4. Inflammatory diseases 46
CHAPTER 4: GENERAL PATHOPHYSIOLOGY OF AGE–RELATED EYE DISEASES 49
PART 2: CLINICAL ASPECTS OF EYE DISORDERS
CHAPTER 5: PRESBYOPIA 65
CHAPTER 6: DYSFUNCTIONAL LENS SYNDROME 73
CHAPTER 7: CATARACT 79
CHAPTER 8: GLAUCOMA 85
CHAPTER 9: AGE–RELATED MACULAR DEGENERATION 93
CHAPTER 10: DIABETIC RETINOPATHY 101
CHAPTER 11: RETINITIS PIGMENTOSA 109
CHAPTER 12: RETINAL VEIN OCCLUSION 115
CHAPTER 13: RETINAL DETACHMENT 123
CHAPTER 14: DRY EYE SYNDROME 129
PART 3: BIOREGENERATIVE MEDICINE IN AGE-ASSOCIATED EYE DISEASES
CHAPTER 15: LIFESTYLE MODIFICATION IN AGE–RELATED VISUAL ISSUES 139
CHAPTER 16: ADVANCED BIOREGENERATIVE APPROACHES IN OPHTHALMOLOGY 159
16.1. Stem cell therapy 162
16.2. Peptide therapy 168
16.3. Exosomes 172
16.4. Mitochondrial replacement 175
CHAPTER 17: BIOREGENERATIVE MEDICINE FOR SPECIFIC EYE DISORDERS 179
17.1. Presbyopia 180
17.2. Dry eye syndrome 182
17.3. Cataract 185
17.4. Glaucoma 187
17.5. Retinitis pigmentosa 189
17.6. Diabetic retinopathy 191
17.7. Age–related macular degeneration 193
17.8. Retinal detachment 194
17.9. Retinal vein occlusion 196
CHAPTER 18: EYES: PRINCIPLES OF HEALTHY AGEING 199
SUMMARY 205
REFERENCES 207
Share this post:
Back To Top